Clinical Trial Update: Biomarkers for the Progression of IgA Nephropathy

View source ↗

Summary

A completed clinical trial from Istanbul University studied biomarkers for the progression of IgA nephropathy and related glomerular diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glomerular Diseases
• Iga Nephropathy

Snippet

Sponsor: Istanbul University | Conditions: IgA Nephropathy, Glomerular Diseases | Status: COMPLETED